Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, January 06, 2010

A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors — CCR

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.